Angle Closure Glaucoma
11
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Testing YAG Laser Iridotomy for Primary Angle-Closure Glaucoma
Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
Diagnostic Performance of Deep Learning for Angle Closure
Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade
Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy
Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy
Comparison of Gonioscopy With Cirrus and Visante
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies
Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure